2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Cutaneous Squamous Cell Carcinoma: new trials by email Literature Review of Cutaneous Squamous Cell Carcinoma trials Research Report on Cutaneous Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors Copaxone - Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma | Phase 1 | Unknown | University of Kansas Medical Center | 10 | 2019-07-26 | 2023-05-19 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer GZ17-6.02, Capecitabine - Advanced Cancer, Gastric Cancer | Phase 1 | Unknown | Genzada Pharmaceuticals USA, Inc. | 127 | 2019-03-01 | 2022-12-23 |
Carcinoma, Basal Cell (2) · Breast Neoplasms (1) · Carcinoma, Squamous Cell (1) · Colonic Neoplasms (1) · Lymphoma (1) · Lymphoma, T-Cell, Cutaneous (1) · Pancreatic Neoplasms (1) · Sarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1)
Carcinoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Basal Cell (2) · Neoplasms, Glandular and Epithelial (2) · Breast Diseases (1) · Carcinoma, Squamous Cell (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
Capecitabine (1) · Coat Protein Complex I (1) · Glatiramer Acetate (1)
Genzada Pharmaceuticals USA, Inc. (1) · University of Kansas Medical Center (1)
United States (2)
Joaquina Baranda, MD (1) · Kathryn Gazarik (1)